eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Draft Guidance for Industry on Use of Histology in Biomarker Qualification Studies; Availabilty
Draft Guidance for Industry on Use of Histology in Biomarker Qualification Studies; Availabilty
Document ID:
FDA-2011-D-0872-0001
Document Type:
Notice
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2011-33553
View Document:
Details Information
Document Subtype:
Notice of Availability
Received Date:
December 30 2011, at 12:00 AM Eastern Standard Time
Start-End Page:
82306 - 82308
Page Count:
3
Comment Start Date:
December 30 2011, at 12:00 AM Eastern Standard Time
Comment Due Date:
March 29 2012, at 11:59 PM Eastern Standard Time
Comments
View All
Total:
18
Society of Toxicologic Pathology (STP) - Comment
Posted:
04/12/2012
ID:
FDA-2011-D-0872-0009
Comment Period Closed
Mar 29,2012 11:59 PM ET
MedImmune, LLC - Comment
Posted:
02/28/2012
ID:
FDA-2011-D-0872-0003
Comment Period Closed
Mar 29,2012 11:59 PM ET
Erio Barale-Thomas - Comment
Posted:
02/28/2012
ID:
FDA-2011-D-0872-0004
Comment Period Closed
Mar 29,2012 11:59 PM ET
Erio Barale-Thomas - Comment
Posted:
02/28/2012
ID:
FDA-2011-D-0872-0005
Comment Period Closed
Mar 29,2012 11:59 PM ET
AstraZeneca - Comment
Posted:
04/12/2012
ID:
FDA-2011-D-0872-0007
Comment Period Closed
Mar 29,2012 11:59 PM ET
Related Documents
Total:
0
No documents available.
Draft Guidance for Industry on Use of Histology in Biomarker Qualification Studies; Availabilty
Details Information
Comments
View AllPosted: 04/12/2012 ID: FDA-2011-D-0872-0009
Mar 29,2012 11:59 PM ET
Posted: 02/28/2012 ID: FDA-2011-D-0872-0003
Mar 29,2012 11:59 PM ET
Posted: 02/28/2012 ID: FDA-2011-D-0872-0004
Mar 29,2012 11:59 PM ET
Posted: 02/28/2012 ID: FDA-2011-D-0872-0005
Mar 29,2012 11:59 PM ET
Posted: 04/12/2012 ID: FDA-2011-D-0872-0007
Mar 29,2012 11:59 PM ET
Related Documents